Confirm cookie choices
Cookies are pieces of code used to track website usage and give audiences the best possible experience.
Use the buttons to confirm whether you agree with default cookie settings when using ebrd.com.

What we do in Equity

What we do in equity

The EBRD as an equity investor


Minority investor
We are a minority investor taking stakes of up to 35% and investing between €10 million and €200 million per investment


Wide range of investment instruments
We are one of the largest and longest standing equity investors in the countries where we work, looking to invest up to  €1 billion annually through straight equity, mezzanine products, preference shares and other instruments


Private and listed investments
In addition to private equity, we also invest in public equities to promote the development of capital markets in our regions by participating in pre-IPO financing, IPOs, capital increases and other public transactions


Variety of deal types
We have a wide mandate that allows us to invest not just in growth capital opportunities but also in investments with longer investment horizons, privatisations and others


Patient capital
Investing from our own balance sheet allows us the flexibility to be long term, patient investors, with longer investment horizons than typical private equity holding periods


Local presence
With our team members present in Bucharest, Cairo, Istanbul, London, Kiev and Warsaw, we leverage our local offices on equity deal origination, execution and monitoring


Comprehensive sector coverage

We have over three decades of experience of equity and debt investments in the following sectors, a wide network of internal and external sector specialists, an unmatched presence on the ground through our network of offices and a successful history of co-investments with strategic and financial investors from our regions and beyond

Agribusiness

Consumer and Retail

Energy

Financial Institutions

Manufacturing and Services

TMT

Natural Resources

Property and Tourism

Healthcare and Pharmaceuticals

Infrastructure

GDPR Cookie Status